Sencilia
Sencilia develops Rely-V, a non-contact MEMS sensor technology designed to monitor intravenous (IV) infusion flow rates in real-time. The technology specifically targets the neonatal and pediatric intensive care markets to detect flow rate errors and occlusions at extremely low infusion rates. The company operates as a spin-out from the University of Groningen and is currently in the pre-clinical development phase.
Visit websiteGroningen, Netherlands
Healthtech
Medical Devices
Deep Tech
Pediatrics
Funding summary
- Total raised
- €0
- Funding rounds
- 1
Investors in Sencilia
Investors on record for Sencilia. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Sencilia?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors